<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01636154</url>
  </required_header>
  <id_info>
    <org_study_id>BUCMDFH9634</org_study_id>
    <nct_id>NCT01636154</nct_id>
  </id_info>
  <brief_title>Clinical Application and Basic Study of Medicinal Fractions-based Herbal Combinations</brief_title>
  <official_title>Clinical Application and Basic Study of Medicinal Fractions-based Herbal Combinations:A Prospective Randomized Controlled Multi-site Clinical Trial About Fractions-based Herbal Combinations of Clearing Heat and Promoting Blood Circulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yunling Zhang</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shandong University of Traditional Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Huairou Hospital of Traditional Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Dongfang Hospital Affiliated to Beijing University of Chinese Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the efficacy of fractions-based herbal
      combinations of clearing heat and promoting blood circulation treating acute ischemic stroke
      and the potential mechanism of it.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The interaction between fire-heat and blood stasis is a significant mechanism underlying
      pathogenesis and progress in acute ischemic stroke according to TCM theory.Clinical
      therapeutic effects are achieved with wide application of Ixeris of sonchifolia Hance
      components (KDZ injection) representing method of clearing heat and Panax notoginseng
      saponins components (Xueshuantong injection) representing method of promoting blood
      circulation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">August 2016</completion_date>
  <primary_completion_date type="Actual">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Ischemic Stroke</condition>
  <arm_group>
    <arm_group_label>The basic treatment</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Comply to the Chinese guidelines of acute ischemic stroke in 2010</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Clearing heat</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Treat with KDZ injection on the basis of the basic treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Promoting blood circulation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Treat with Xueshuantong injection on the basis of the basic treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Clearing heat &amp; Promoting blood circulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treat with both KDZ injection and Xueshuantong injection on the basis of the basic treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ixeris of sonchifolia Hance</intervention_name>
    <description>KDZ40ml+0.9%N.S.250ml,ivdrip,qd of each 14-day cycle.Number of cycles:one.</description>
    <arm_group_label>Clearing heat</arm_group_label>
    <other_name>KDZ injection</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Panax notoginseng saponins</intervention_name>
    <description>Xueshuantong450mg+0.9%N.S.250ml,ivdrip,qd of each 14-day cycle.Number of cycles:one.</description>
    <arm_group_label>Promoting blood circulation</arm_group_label>
    <other_name>Xueshuantong injection</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ixeris of sonchifolia Hance combined with Panax notoginseng saponins</intervention_name>
    <description>KDZ40ml+0.9%N.S.250ml,ivdrip;0.9%N.S.50ml,ivdrip;Xueshuantong450mg+0.9%N.S.250ml,ivdrip.qd of each 14-day cycle.Number of cycles:one.</description>
    <arm_group_label>Clearing heat &amp; Promoting blood circulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with acute ischemic stroke

          -  Patients with fire-heat syndrome

          -  Stoke onset within 48 hours

          -  NIHSS scores range from 5 points to 25 points

          -  Age from forty to seventy-five,gender not limited

          -  Informed and signed the consent

        Exclusion Criteria:

          -  Cardiogenic cerebral embolism,stroke caused by other reasons or the unexplained

          -  Patients suitable for thrombolytic therapy(rt-PA, urokinase)

          -  Patients have received thrombolytic therapy

          -  Patients with serious diseases of heart,lungs,liver,kidneys

          -  Patients with bleeding or bleeding tendency recently

          -  Pregnant or lactating women

          -  Pre-existing neurological or psychiatric diseases that could confound the study
             results

          -  Patients be allergic to alcohol,Ixeris of sonchifolia Hance components (KDZ injection)
             or Panax notoginseng saponins components (Xueshuantong injection)

          -  Patients have participated in other clinical trials within 3 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yunling Zhang, PhD,MD</last_name>
    <role>Study Chair</role>
    <affiliation>Dongfang Hospital,Beijing University of Chinese Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Neurology,Dongfang Hospital,Beijing University of Chinese Medicine</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100078</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology,Huairou Hospital of Traditional Chinese Medicine</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>101400</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology,Affiliated Hospital of Shandong University of Traditional Chinese Medicine</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <zip>250011</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 29, 2012</study_first_submitted>
  <study_first_submitted_qc>July 5, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 10, 2012</study_first_posted>
  <last_update_submitted>August 4, 2016</last_update_submitted>
  <last_update_submitted_qc>August 4, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 5, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Dongfang Hospital Affiliated to Beijing University of Chinese Medicine</investigator_affiliation>
    <investigator_full_name>Yunling Zhang</investigator_full_name>
    <investigator_title>President of of Dongfang Hospital</investigator_title>
  </responsible_party>
  <keyword>fire-heat syndrome</keyword>
  <keyword>blood stasis syndrome</keyword>
  <keyword>method of clearing heat</keyword>
  <keyword>method of promoting blood circulation</keyword>
  <keyword>medicinal fractions-based herbal combinations</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

